Evidence map›Paper›PMID 38486002›Full record

ArticleCommunications biology2024

Genomic diversity of the pathogenic fungus Aspergillus fumigatus in Japan reveals the complex genomic basis of azole resistance.

Xiaohui He, Yoko Kusuya, Daisuke Hagiwara, Takahito Toyotome, Teppei Arai, Cai Bian, Masaki Nagayama, Saho Shibata, Akira Watanabe, Hiroki Takahashi

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. PCR Typing and Genome Sequencing of Aspergillus fumigatus.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  8. Article
  9. Effect of Mn(II) and Co(II) on Anti-Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  10. Ascorbic Acid Enhances the Inhibitory Effect of Theasaponins againstInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Xiaohui He *Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0009-0009-0275-5275
Yoko Kusuya *Biological Resource Center, National Institute of Technology and Evaluation, 2-5-8 Kazusakamatari, Kisarazu, 292-0818, Japan.ORCID 0000-0002-5724-487X
Daisuke HagiwaraMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0000-0003-1382-3914
Takahito ToyotomeMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0000-0003-2822-2767
Teppei AraiMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0000-0002-2798-5829
Cai BianBGI-Shenzhen, Yantian District, Shenzhen, 518083, China.ORCID 0009-0004-8207-7892
Masaki NagayamaGraduate School of Medical and Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.ORCID 0009-0005-5447-146X
Saho ShibataMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0000-0003-2336-6948
Akira WatanabeMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan.ORCID 0000-0002-3057-2937
Hiroki TakahashiMedical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8673, Japan. hiroki.takahashi@chiba-u.jp.ORCID 0000-0001-5627-1035
Chiba University Hospital · JPChiba University · JPBGI Group (China) · CNNational Institute of Technology and Evaluation · JPUniversity of Tsukuba · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP19fm0208024Japan Agency for Medical Research and Development (AMED) JP23gm1610004MEXT | Japan Society for the Promotion of Science (JSPS) JP21K07001MEXT | Japan Society for the Promotion of Science (JSPS) JP21K18217MEXT | Japan Society for the Promotion of Science (JSPS) JP22H04925
6 · The paper itself

Abstract

Aspergillus fumigatus is a pathogenic fungus with a global distribution. The emergence of azole-resistant A. fumigatus (ARAf) other than the TR-mutants is a problem in Japan. Additionally, the genetic diversity of A. fumigatus strains in Japan remains relatively unknown. Here we show the diversity in the A. fumigatus strains isolated in Japan as well as the complexity in the global distribution of the pathogenic strains. First, we analyzed the genome sequences of 171 strains from Japan as well as the antifungal susceptibility of these strains. Next, we conducted a population analysis of 876 strains by combining the available genomic data for strains isolated worldwide, which were grouped in six clusters. Finally, a genome-wide association study identified the genomic loci associated with ARAf strains, but not the TR-mutants. These results highlight the complexity of the genomic mechanism underlying the emergence of ARAf strains other than the TR-mutants.

Indexed as

Aspergillus fumigatusAzolesDrug Resistance, FungalGenome-Wide Association StudyGenomicsJapanAzoles

Identifiers

PMID38486002
PMCPMC10940670
OpenAlexW4392808556

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.